Collagenase and collagenase inhibitor levels following changes in bone resorption in vitro.
D000818:Animals; D001862:Bone Resorption / Q000201:enzymology / Q000378:metabolism*; D002116:Calcitonin / Q000494:pharmacology; D003094:Collagen / Q000032:analysis / Q000378:metabolism; D004100:Dihydroxycholecalciferols / Q000494:pharmacology; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000032:analysis*; D006854:Hydrocortisone / Q000494:pharmacology; D051379:Mice; D003012:Microbial Collagenase / Q000032:analysis* / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D010662:Phenylmercuric Acetate / Q000031:analogs & derivatives; D019714:Tissue Inhibitor of Metalloproteinases; D014357:Trypsin / Q000494:pharmacology; D014801:Vitamin A / Q000494:pharmacology
D004100:Dihydroxycholecalciferols; D004791:Enzyme Inhibitors; D019714:Tissue Inhibitor of Metalloproteinases; D014801:Vitamin A; C010024:4-aminophenylmercuriacetate; D002116:Calcitonin; D003094:Collagen; D014357:Trypsin; D003012:Microbial Collagenase; D010662:Phenylmercuric Acetate; D006854:Hydrocortisone